Detalles de la búsqueda
1.
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844002
2.
The effect of food on the pharmacokinetics of oral ivermectin.
J Antimicrob Chemother
; 75(2): 438-440, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31691813
3.
Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
AIDS Res Ther
; 14(1): 20, 2017 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28376815
4.
Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study.
AIDS Res Ther
; 12: 39, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26628902
5.
Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
BMC Infect Dis
; 14: 664, 2014 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472544
6.
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Clin Pharmacokinet
; 63(5): 721-728, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573477
7.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Lancet HIV
; 11(5): e300-e308, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621393
8.
Access to novel anti-diabetic agents in resource limited settings: A brief commentary.
World J Diabetes
; 14(7): 939-941, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37547585
9.
Optimal dosing of gliclazide-A model-based approach.
Basic Clin Pharmacol Toxicol
; 133(1): 59-72, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999176
10.
Association of antiretroviral therapy adherence and health care costs.
Ann Intern Med
; 152(1): 18-25, 2010 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20048268
11.
Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Wien Klin Wochenschr
; 133(15-16): 840-846, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837463
12.
Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings.
BMC Health Serv Res
; 10 Suppl 1: S3, 2010 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20594369
13.
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
Adv Ther
; 37(1): 27-40, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31673991
14.
The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
Cardiovasc J Afr
; 31(5): 245-251, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33151240
15.
PCSK9 Inhibitors: From Nature's Lessons to Clinical Utility.
Endocr Metab Immune Disord Drug Targets
; 20(6): 840-854, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32053090
16.
Management of adult patients with type 1 diabetes mellitus in Africa: A post-hoc cohort analysis of 12 African countries participating in the International Diabetes Management Practices Study (Wave 7).
Medicine (Baltimore)
; 99(25): e20553, 2020 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32569176
17.
Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
PLoS Med
; 6(12): e1000189, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19956658
18.
A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy.
J Acquir Immune Defic Syndr
; 80(3): 325-329, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30531296
19.
Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Clin Pharmacokinet
; 63(5): 729-730, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696004
20.
Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy.
Medicine (Baltimore)
; 95(9): e2844, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26945366